Since the 2010 publication of the "SHEA Guideline for the Management of Healthcare Workers Who Are Infected with Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and/or Human Immunodeficiency Virus (HIV)" (1), additional strides have been made in the therapy of these three bloodborne pathogens. Effective treatments offer the promise of sustained virologic control, further reducing the already exceedingly small risk of transmission from an infected healthcare provider to a patient.

View PDF (280 KB)